ClinicalTrials.Veeva

Menu

Anterior Cervical Discectomy and Fusion (ACDF) - Behavioral Intervention

NYU Langone Health logo

NYU Langone Health

Status

Enrolling

Conditions

Dysphagia

Treatments

Behavioral: Proactive pharyngeal-laryngeal Exercise Program
Behavioral: Hydration Counseling
Dietary Supplement: Premier Protein Clear ® High Protein

Study type

Interventional

Funder types

Other

Identifiers

NCT06520579
24-00667

Details and patient eligibility

About

This study will prospectively recruit and enroll patients undergoing primary Anterior Cervical Discectomy and Fusion (ACDF) surgeries at NYU Langone. Participants will undergo pre-operative and six-week post-operative swallowing assessment using videofluoroscopy (VFSS). Acoustic voice samples and Patient Reported Outcome Measures (PROMs) for swallowing and voice will also be collected. Beginning one-week before surgery participants will begin a behavioral health program that will be continued for six-weeks after surgery. The primary goal of this study will be to determine whether a preventative behavioral health program improves instrumental measures of swallowing and voice six-weeks after ACDF surgery. .

Enrollment

50 estimated patients

Sex

All

Ages

21 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Able and willing to sign consent form to participate in the study.
  2. Age between 21- 99 years.
  3. Scheduled to undergo ACDF surgery with surgeons in the departments of Neurosurgery or Orthopedic Surgery at NYU Langone.

Exclusion criteria

  1. Patients with non-degenerative spine conditions, such as trauma, tumors, infection, radiation, and diabetes.
  2. Patients with prior posterior-approach cervical spine procedures.
  3. Patients undergoing ACDF revision procedures.
  4. Patients who report a pre-existing dysphagia as the result of a neurological deficit or disorder, head and neck cancer treatment, and/or muscular condition.
  5. Pregnancy. Female subjects must confirm they are not pregnant before enrolling in the study.
  6. Patients with chronic kidney disease, limiting their ability to consume high levels of protein.
  7. Patients with known allergies to ingredients listed in Premier Protein Clear drinks.

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Proactive Behavioral Intervention coupled with protein supplementation
Experimental group
Description:
Patients will receive the behavioral intervention program comprised of hydration counseling, protein supplementation, and daily pharyngeal/laryngeal exercise for a total of 7 weeks.
Treatment:
Dietary Supplement: Premier Protein Clear ® High Protein
Behavioral: Hydration Counseling
Behavioral: Proactive pharyngeal-laryngeal Exercise Program
Historical Control Group
No Intervention group
Description:
Historical control data from subjects who underwent Anterior Cervical Discectomy and Fusion (ACDF) surgery but did not receive any behavioral intervention.

Trial contacts and locations

1

Loading...

Central trial contact

Sonja Molfenter, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems